AAAAAA
Results:
1-12
|
Results: 12
Authors:
Hokken-Koelega, ACS
Saenger, P
Cappa, M
Greggio, N
Citation: Acs. Hokken-koelega et al., Unresolved problems concerning optimal therapy of puberty in children withchronic renal diseases, J PED END M, 14, 2001, pp. 945-952
Authors:
Bozzola, M
Albanese, A
Butler, GE
Cherubini, V
Cicognani, A
Caruso-Nicoletti, M
Crowne, E
De Sanctis, V
Di Battista, E
Hokken-Koelega, ACS
Severi, F
Wonke, B
Cavallo, L
Citation: M. Bozzola et al., Unresolved problems in optimal therapy of pubertal disorders in oncological and bone marrow transplanted patients, J PED END M, 14, 2001, pp. 997-1002
Authors:
van der Sluis, IM
Boot, AM
Nauta, J
Hop, WCJ
de Jong, MCJW
Lilien, MR
Groothoff, JW
van Wijk, AE
Pols, HAP
Hokken-Koelega, ACS
Keizer-Schrama, SMPFD
Citation: Im. Van Der Sluis et al., Bone density and body composition in chronic renal failure: effects of growth hormone treatment, PED NEPHROL, 15(3-4), 2000, pp. 221-228
Authors:
Sas, TCJ
Gerver, WJM
de Bruin, R
Mulder, PGH
Cole, TJ
de Waal, W
Hokken-Koelega, ACS
Citation: Tcj. Sas et al., Body proportions during 6 years of GH treatment in children with short stature born small for gestational age participating in a randomised, double-blind, dose-response trial, CLIN ENDOCR, 53(6), 2000, pp. 675-681
Authors:
Huysman, MWA
Hokken-Koelega, ACS
De Ridder, MAJ
Sauer, PJJ
Citation: Mwa. Huysman et al., Adrenal function in sick very preterm infants, PEDIAT RES, 48(5), 2000, pp. 629-633
Authors:
Joosten, KFM
De Kleijn, ED
Westerterp, M
De Hoog, M
Eijck, FCV
Hop, WCJ
Voort, EV
Hazelzet, JA
Hokken-Koelega, ACS
Citation: Kfm. Joosten et al., Endocrine and metabolic responses in children with meningoccocal sepsis: Striking differences between survivors and nonsurvivors, J CLIN END, 85(10), 2000, pp. 3746-3753
Authors:
Muller, J
Skakkebaek, NE
Jacobsen, BB
Keller, E
Heinrich, U
Hartmann, K
Hokken-Koelega, ACS
van de Waal, HAD
Citation: J. Muller et al., Norditropin (R) SimpleXx (TM): A liquid human growth hormone formulation, a pen system and an auto-insertion device, HORMONE RES, 51, 1999, pp. 109-112
Authors:
Van Doorn, J
Ringeling, AM
Shmueli, SS
Kuijpers, MC
Hokken-Koelega, ACS
van Buul-Offers, SC
Jansen, M
Citation: J. Van Doorn et al., Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay, CLIN ENDOCR, 50(5), 1999, pp. 601-609
Authors:
Sas, TCJ
Keizer-Schrama, SMPFD
Stijnen, T
van Teunenbroek, A
Hokken-Koelega, ACS
Waelkens, JJJ
Massa, GG
Vulsma, T
Gerver, WJ
Reeser, HM
Delemarre-van de Waal, HE
Jansen, M
Drop, SLS
Citation: Tcj. Sas et al., Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections, ARCH DIS CH, 80(1), 1999, pp. 36-41
Authors:
Hokken-Koelega, ACS
Citation: Acs. Hokken-koelega, What is the role of GH therapy in children born small for gestational age?, CHALLENGES IN GROWTH HORMONE THERAPY, 1999, pp. 78-90
Authors:
Boot, AM
Nauta, J
de Jong, MCJW
Groothoff, JW
Lilien, MR
van Wijk, JAE
Holthe, JEKV
Hokken-Koelega, ACS
Pols, HAP
Keizer-Schrama, SMPFD
Citation: Am. Boot et al., Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment, CLIN ENDOCR, 49(5), 1998, pp. 665-672
Authors:
Hokken-Koelega, ACS
Citation: Acs. Hokken-koelega, Endocrinology - Can we escape our genetic destiny?, LANCET, 352, 1998, pp. 8-8
Risultati:
1-12
|